Last 12 months
Inside the activity.
0 purchase rows · 10 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 3 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 1 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 3 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 1 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 24, 2023 Filed Apr 26, 2023 21:13 UTC |
SURESH SUBRADirector
|
GrantCommon Stock | 7,466 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-025719 · doc4.xml · nonDerivative · entry 1 SURESH SUBRA · CIK 0001658316 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 65,132 F1 · shares: On April 24, 2023, the reporting person was granted 7,466 restricted stock units, all of which vested on the grant date. Read SEC document |
| April 24, 2023 Filed Apr 26, 2023 21:13 UTC |
Rucker Kim K.W.Director
|
GrantRestricted Stock Units · Derivative | 7,466 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-025718 · doc4.xml · derivative · entry 1 Rucker Kim K.W. · CIK 0001430329 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,466 Underlying: Common Stock · 7,466 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of HP common stock. F2 · shares: On April 24, 2023, the reporting person was granted 7,466 RSUs, all of which vested on the grant date. F2 · price: On April 24, 2023, the reporting person was granted 7,466 RSUs, all of which vested on the grant date. F2 · derivative.exercise_date: On April 24, 2023, the reporting person was granted 7,466 RSUs, all of which vested on the grant date. F3 · derivative.exercise_date: The reporting person elected to defer the receipt of common stock until the termination of her service as a member of HP's Board of Directors. F2 · derivative.expiration_date: On April 24, 2023, the reporting person was granted 7,466 RSUs, all of which vested on the grant date. Read SEC document |
| April 24, 2023 Filed Apr 26, 2023 21:12 UTC |
Miscik Judith ADirector
|
GrantCommon Stock | 7,466 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-025717 · doc4.xml · nonDerivative · entry 1 Miscik Judith A · CIK 0001555318 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,407 F1 · shares: On April 24, 2023, the reporting person was granted 7,466 restricted stock units, all of which vested on the grant date. Read SEC document |
| April 24, 2023 Filed Apr 26, 2023 21:12 UTC |
CLEMMER RICHARD LDirector
|
GrantRestricted Stock Units · Derivative | 3,563 | $29.47 | $105,001.61 |
DisclosureSEC source: 0001209191-23-025716 · doc4.xml · derivative · entry 2 CLEMMER RICHARD L · CIK 0001222781 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,563 Underlying: Common Stock · 3,563 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of HP common stock. F4 · shares: On April 24, 2023, the reporting person was granted 3,563 RSUs, all of which vested on the grant date. These RSUs were issued to the reporting person in lieu of the annual director cash retainer. F4 · price: On April 24, 2023, the reporting person was granted 3,563 RSUs, all of which vested on the grant date. These RSUs were issued to the reporting person in lieu of the annual director cash retainer. F3 · derivative.exercise_date: The reporting person elected to defer the receipt of common stock until the termination of his service as a member of HP's Board of Directors. F4 · derivative.exercise_date: On April 24, 2023, the reporting person was granted 3,563 RSUs, all of which vested on the grant date. These RSUs were issued to the reporting person in lieu of the annual director cash retainer. F4 · derivative.expiration_date: On April 24, 2023, the reporting person was granted 3,563 RSUs, all of which vested on the grant date. These RSUs were issued to the reporting person in lieu of the annual director cash retainer. Read SEC document |
| April 24, 2023 Filed Apr 26, 2023 21:12 UTC |
CLEMMER RICHARD LDirector
|
GrantRestricted Stock Units · Derivative | 7,466 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-025716 · doc4.xml · derivative · entry 1 CLEMMER RICHARD L · CIK 0001222781 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,466 Underlying: Common Stock · 7,466 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of HP common stock. F2 · shares: On April 24, 2023, the reporting person was granted 7,466 RSUs, all of which vested on the grant date. F2 · price: On April 24, 2023, the reporting person was granted 7,466 RSUs, all of which vested on the grant date. F2 · derivative.exercise_date: On April 24, 2023, the reporting person was granted 7,466 RSUs, all of which vested on the grant date. F3 · derivative.exercise_date: The reporting person elected to defer the receipt of common stock until the termination of his service as a member of HP's Board of Directors. F2 · derivative.expiration_date: On April 24, 2023, the reporting person was granted 7,466 RSUs, all of which vested on the grant date. Read SEC document |
| April 24, 2023 Filed Apr 26, 2023 21:11 UTC |
Citrino Mary AnneDirector
|
GrantRestricted Stock Units · Derivative | 3,563 | $29.47 | $105,001.61 |
DisclosureSEC source: 0001209191-23-025715 · doc4.xml · derivative · entry 2 Citrino Mary Anne · CIK 0001334494 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,563 Underlying: Common Stock · 3,563 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of HP common stock. F4 · shares: On April 24, 2023, the reporting person was granted 3,563 RSUs, all of which vested on the grant date. These RSUs were issued to the reporting person in lieu of the annual director cash retainer. F4 · price: On April 24, 2023, the reporting person was granted 3,563 RSUs, all of which vested on the grant date. These RSUs were issued to the reporting person in lieu of the annual director cash retainer. F3 · derivative.exercise_date: The reporting person elected to defer the receipt of common stock until the termination of her service as a member of HP's Board of Directors. F4 · derivative.exercise_date: On April 24, 2023, the reporting person was granted 3,563 RSUs, all of which vested on the grant date. These RSUs were issued to the reporting person in lieu of the annual director cash retainer. F4 · derivative.expiration_date: On April 24, 2023, the reporting person was granted 3,563 RSUs, all of which vested on the grant date. These RSUs were issued to the reporting person in lieu of the annual director cash retainer. Read SEC document |
| April 24, 2023 Filed Apr 26, 2023 21:11 UTC |
Citrino Mary AnneDirector
|
GrantRestricted Stock Units · Derivative | 7,466 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-025715 · doc4.xml · derivative · entry 1 Citrino Mary Anne · CIK 0001334494 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,466 Underlying: Common Stock · 7,466 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of HP common stock. F2 · shares: On April 24, 2023, the reporting person was granted 7,466 RSUs, all of which vested on the grant date. F2 · price: On April 24, 2023, the reporting person was granted 7,466 RSUs, all of which vested on the grant date. F2 · derivative.exercise_date: On April 24, 2023, the reporting person was granted 7,466 RSUs, all of which vested on the grant date. F3 · derivative.exercise_date: The reporting person elected to defer the receipt of common stock until the termination of her service as a member of HP's Board of Directors. F2 · derivative.expiration_date: On April 24, 2023, the reporting person was granted 7,466 RSUs, all of which vested on the grant date. Read SEC document |
| April 24, 2023 Filed Apr 26, 2023 21:11 UTC |
BURNS STEPHANIEDirector
|
GrantRestricted Stock Units · Derivative | 7,466 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-025714 · doc4.xml · derivative · entry 1 BURNS STEPHANIE · CIK 0001257094 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,466 Underlying: Common Stock · 7,466 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of HP common stock. F2 · shares: On April 24, 2023, the reporting person was granted 7,466 RSUs, all of which vested on the grant date. F2 · price: On April 24, 2023, the reporting person was granted 7,466 RSUs, all of which vested on the grant date. F2 · derivative.exercise_date: On April 24, 2023, the reporting person was granted 7,466 RSUs, all of which vested on the grant date. F3 · derivative.exercise_date: The reporting person elected to defer the receipt of common stock until the termination of her service as a member of HP's Board of Directors. F2 · derivative.expiration_date: On April 24, 2023, the reporting person was granted 7,466 RSUs, all of which vested on the grant date. Read SEC document |
| April 24, 2023 Filed Apr 26, 2023 21:11 UTC |
BROWN-PHILPOT STACYDirector
|
GrantRestricted Stock Units · Derivative | 7,466 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-025713 · doc4.xml · derivative · entry 1 BROWN-PHILPOT STACY · CIK 0001656243 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,466 Underlying: Common Stock · 7,466 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of HP common stock. F2 · shares: On April 24, 2023, the reporting person was granted 7,466 RSUs, all of which vested on the grant date. F2 · price: On April 24, 2023, the reporting person was granted 7,466 RSUs, all of which vested on the grant date. F2 · derivative.exercise_date: On April 24, 2023, the reporting person was granted 7,466 RSUs, all of which vested on the grant date. F3 · derivative.exercise_date: The reporting person elected to defer the receipt of common stock until the termination of her service as a member of HP's Board of Directors. F2 · derivative.expiration_date: On April 24, 2023, the reporting person was granted 7,466 RSUs, all of which vested on the grant date. Read SEC document |
| April 24, 2023 Filed Apr 26, 2023 21:10 UTC |
BROUSSARD BRUCE DDirector
|
GrantCommon Stock | 3,563 | $29.47 | $105,001.61 |
DisclosureSEC source: 0001209191-23-025710 · doc4.xml · nonDerivative · entry 2 BROUSSARD BRUCE D · CIK 0001185643 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,739 F2 · shares: On April 24, 2023, the reporting person was granted 3,563 RSUs, all of which vested on the grant date. These RSUs were issued to the reporting person in lieu of the annual director cash retainer. Read SEC document |
| April 24, 2023 Filed Apr 26, 2023 21:10 UTC |
BROUSSARD BRUCE DDirector
|
GrantCommon Stock | 7,466 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-025710 · doc4.xml · nonDerivative · entry 1 BROUSSARD BRUCE D · CIK 0001185643 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,176 F1 · shares: On April 24, 2023, the reporting person was granted 7,466 restricted stock units ("RSUs"), all of which vested on the grant date. Read SEC document |
| April 24, 2023 Filed Apr 26, 2023 21:10 UTC |
Bergh Charles VDirector
|
GrantRestricted Stock Units · Derivative | 3,563 | $29.47 | $105,001.61 |
DisclosureSEC source: 0001209191-23-025708 · doc4.xml · derivative · entry 2 Bergh Charles V · CIK 0001436534 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,563 Underlying: Common Stock · 3,563 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of HP common stock. F4 · shares: On April 24, 2023, the reporting person was granted 3,563 RSUs, all of which vested on the grant date. These RSUs were issued to the reporting person in lieu of the annual director cash retainer. F4 · price: On April 24, 2023, the reporting person was granted 3,563 RSUs, all of which vested on the grant date. These RSUs were issued to the reporting person in lieu of the annual director cash retainer. F3 · derivative.exercise_date: The reporting person elected to defer the receipt of common stock until April 1, 2030. F4 · derivative.exercise_date: On April 24, 2023, the reporting person was granted 3,563 RSUs, all of which vested on the grant date. These RSUs were issued to the reporting person in lieu of the annual director cash retainer. F4 · derivative.expiration_date: On April 24, 2023, the reporting person was granted 3,563 RSUs, all of which vested on the grant date. These RSUs were issued to the reporting person in lieu of the annual director cash retainer. Read SEC document |
| April 24, 2023 Filed Apr 26, 2023 21:10 UTC |
Bergh Charles VDirector
|
GrantRestricted Stock Units · Derivative | 7,466 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-025708 · doc4.xml · derivative · entry 1 Bergh Charles V · CIK 0001436534 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,466 Underlying: Common Stock · 7,466 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of HP common stock. F2 · shares: On April 24, 2023, the reporting person was granted 7,466 RSUs, all of which vested on the grant date. F2 · price: On April 24, 2023, the reporting person was granted 7,466 RSUs, all of which vested on the grant date. F2 · derivative.exercise_date: On April 24, 2023, the reporting person was granted 7,466 RSUs, all of which vested on the grant date. F3 · derivative.exercise_date: The reporting person elected to defer the receipt of common stock until April 1, 2030. F2 · derivative.expiration_date: On April 24, 2023, the reporting person was granted 7,466 RSUs, all of which vested on the grant date. Read SEC document |
| April 24, 2023 Filed Apr 26, 2023 21:09 UTC |
BENNETT ROBERT RDirector
|
GrantRestricted Stock Units · Derivative | 7,466 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-025706 · doc4.xml · derivative · entry 1 BENNETT ROBERT R · CIK 0001119603 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,466 Underlying: Common Stock · 7,466 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of HP common stock. F2 · shares: On April 24, 2023, the reporting person was granted 7,466 RSUs, all of which vested on the grant date. F2 · price: On April 24, 2023, the reporting person was granted 7,466 RSUs, all of which vested on the grant date. F2 · derivative.exercise_date: On April 24, 2023, the reporting person was granted 7,466 RSUs, all of which vested on the grant date. F3 · derivative.exercise_date: The reporting person elected to defer the receipt of common stock until the termination of his service as a member of HP's Board of Directors. F2 · derivative.expiration_date: On April 24, 2023, the reporting person was granted 7,466 RSUs, all of which vested on the grant date. Read SEC document |
| April 24, 2023 Filed Apr 26, 2023 21:09 UTC |
Banerji ShumeetDirector
|
GrantCommon Stock | 3,563 | $29.47 | $105,001.61 |
DisclosureSEC source: 0001209191-23-025704 · doc4.xml · nonDerivative · entry 2 Banerji Shumeet · CIK 0001511649 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 57,737 F2 · shares: On April 24, 2023, the reporting person was granted 3,563 RSUs, all of which vested on the grant date. These RSUs were issued to the reporting person in lieu of the annual director cash retainer. Read SEC document |
| April 24, 2023 Filed Apr 26, 2023 21:09 UTC |
Banerji ShumeetDirector
|
GrantCommon Stock | 7,466 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-025704 · doc4.xml · nonDerivative · entry 1 Banerji Shumeet · CIK 0001511649 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54,174 F1 · shares: On April 24, 2023, the reporting person was granted 7,466 restricted stock units ("RSUs"), all of which vested on the grant date. Read SEC document |
| April 24, 2023 Filed Apr 26, 2023 21:09 UTC |
ALVAREZ AIDADirector
|
GrantCommon Stock | 7,466 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-025703 · doc4.xml · nonDerivative · entry 1 ALVAREZ AIDA · CIK 0001268885 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 59,108 F1 · shares: On April 24, 2023, the reporting person was granted 7,466 restricted stock units, all of which vested on the grant date. Read SEC document |
| April 03, 2023 Filed Apr 3, 2023 22:18 UTC |
MYERS MARIEChief Financial Officer
|
SaleCommon Stock | 4,165 | $29.34 | $122,201.10 |
DisclosureSEC source: 0001209191-23-022354 · doc4.xml · nonDerivative · entry 3 MYERS MARIE · CIK 0001656326 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 43,106 F2 · kind: The sales reported on this Form 4 were executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 9/19/2022. Read SEC document |
| April 03, 2023 Filed Apr 3, 2023 22:17 UTC |
LORES ENRIQUEDirector · President and CEO
|
SaleCommon Stock | 38,000 | $29.51 | $1,121,380.00 |
DisclosureSEC source: 0001209191-23-022353 · doc4.xml · nonDerivative · entry 1 LORES ENRIQUE · CIK 0001656242 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 766,268 F1 · kind: The sales reported on this Form 4 were executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 9/29/2022. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.27-$29.705, inclusive. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| April 01, 2023 Filed Apr 4, 2023 21:02 UTC |
Bergh Charles VDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 10,589 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-23-022795 · doc4.xml · derivative · entry 2 Bergh Charles V · CIK 0001436534 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,589 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of HP common stock. F2 · shares: As previously reported, on 05/05/2016, the reporting person was granted 8,734 RSUs, all of which vested on the one year anniversary of the grant date. The reporting person elected to defer the receipt of HP common stock upon the vesting of RSUs until 04/01/2023. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. The number of derivative securities in column 5 includes 1,855 vested dividend equivalent rights. F2 · price: As previously reported, on 05/05/2016, the reporting person was granted 8,734 RSUs, all of which vested on the one year anniversary of the grant date. The reporting person elected to defer the receipt of HP common stock upon the vesting of RSUs until 04/01/2023. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. The number of derivative securities in column 5 includes 1,855 vested dividend equivalent rights. F2 · derivative.exercise_date: As previously reported, on 05/05/2016, the reporting person was granted 8,734 RSUs, all of which vested on the one year anniversary of the grant date. The reporting person elected to defer the receipt of HP common stock upon the vesting of RSUs until 04/01/2023. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. The number of derivative securities in column 5 includes 1,855 vested dividend equivalent rights. F2 · derivative.expiration_date: As previously reported, on 05/05/2016, the reporting person was granted 8,734 RSUs, all of which vested on the one year anniversary of the grant date. The reporting person elected to defer the receipt of HP common stock upon the vesting of RSUs until 04/01/2023. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. The number of derivative securities in column 5 includes 1,855 vested dividend equivalent rights. Read SEC document |
| April 01, 2023 Filed Apr 4, 2023 21:02 UTC |
Bergh Charles VDirector
|
Exercise / conversionCommon Stock | 10,589 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-022795 · doc4.xml · nonDerivative · entry 1 Bergh Charles V · CIK 0001436534 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,685 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 30, 2023 Filed Apr 3, 2023 22:18 UTC |
MYERS MARIEChief Financial Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 35,551 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-23-022354 · doc4.xml · derivative · entry 4 MYERS MARIE · CIK 0001656326 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 35,551 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of HP common stock. F4 · price: As previously reported, on 03/30/2020, the reporting person was granted 98,094 RSUs, 1/3 of which vest annually over 3 years on the anniversary of the grant date. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. The number of derivative securities in column 5 includes 2,853 vested dividend equivalent rights. F4 · derivative.exercise_date: As previously reported, on 03/30/2020, the reporting person was granted 98,094 RSUs, 1/3 of which vest annually over 3 years on the anniversary of the grant date. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. The number of derivative securities in column 5 includes 2,853 vested dividend equivalent rights. F4 · derivative.expiration_date: As previously reported, on 03/30/2020, the reporting person was granted 98,094 RSUs, 1/3 of which vest annually over 3 years on the anniversary of the grant date. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. The number of derivative securities in column 5 includes 2,853 vested dividend equivalent rights. Read SEC document |
| March 30, 2023 Filed Apr 3, 2023 22:18 UTC |
MYERS MARIEChief Financial Officer
|
Tax withholdingCommon Stock | 10,928 | $28.90 | $315,819.20 |
DisclosureSEC source: 0001209191-23-022354 · doc4.xml · nonDerivative · entry 2 MYERS MARIE · CIK 0001656326 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 47,271 F1 · shares: Shares withheld by HP to satisfy tax withholding upon vesting. Read SEC document |
| March 30, 2023 Filed Apr 3, 2023 22:18 UTC |
MYERS MARIEChief Financial Officer
|
Exercise / conversionCommon Stock | 35,551 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-022354 · doc4.xml · nonDerivative · entry 1 MYERS MARIE · CIK 0001656326 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 58,199 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2023 Filed Mar 2, 2023 23:01 UTC |
MYERS MARIEChief Financial Officer
|
SaleCommon Stock | 7,380 | $29.87 | $220,440.60 |
DisclosureSEC source: 0001209191-23-014891 · doc4.xml · nonDerivative · entry 1 MYERS MARIE · CIK 0001656326 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,648 F1 · kind: The sales reported on this Form 4 were executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 09/19/2022. Read SEC document |
| February 17, 2023 Filed Feb 22, 2023 22:19 UTC |
MYERS MARIEChief Financial Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 13,445 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-23-011762 · doc4.xml · derivative · entry 3 MYERS MARIE · CIK 0001656326 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,684 Underlying: Common Stock · 13,445 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of HP common stock. F3 · shares: As previously reported, on 02/17/2021, the reporting person was granted 38,052 RSUs, 1/3 of which vests annually over 3 years on the anniversary of the grant date. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. The number of derivative securities in column 5 includes 761 vested dividend equivalent rights. F3 · price: As previously reported, on 02/17/2021, the reporting person was granted 38,052 RSUs, 1/3 of which vests annually over 3 years on the anniversary of the grant date. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. The number of derivative securities in column 5 includes 761 vested dividend equivalent rights. F3 · derivative.exercise_date: As previously reported, on 02/17/2021, the reporting person was granted 38,052 RSUs, 1/3 of which vests annually over 3 years on the anniversary of the grant date. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. The number of derivative securities in column 5 includes 761 vested dividend equivalent rights. F3 · derivative.expiration_date: As previously reported, on 02/17/2021, the reporting person was granted 38,052 RSUs, 1/3 of which vests annually over 3 years on the anniversary of the grant date. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. The number of derivative securities in column 5 includes 761 vested dividend equivalent rights. Read SEC document |
| February 17, 2023 Filed Feb 22, 2023 22:19 UTC |
MYERS MARIEChief Financial Officer
|
Tax withholdingCommon Stock | 3,353 | $30.16 | $101,126.48 |
DisclosureSEC source: 0001209191-23-011762 · doc4.xml · nonDerivative · entry 2 MYERS MARIE · CIK 0001656326 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,028 F1 · shares: Shares withheld by HP to satisfy tax withholding upon vesting. Read SEC document |
| February 17, 2023 Filed Feb 22, 2023 22:19 UTC |
MYERS MARIEChief Financial Officer
|
Exercise / conversionCommon Stock | 13,445 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-011762 · doc4.xml · nonDerivative · entry 1 MYERS MARIE · CIK 0001656326 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,381 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 10, 2023 Filed Feb 14, 2023 22:01 UTC |
McQuarrie David P.Chief Commercial Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 13,014 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-23-009214 · doc4.xml · derivative · entry 3 McQuarrie David P. · CIK 0001951912 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,278 Underlying: Common Stock · 13,014 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of HP common stock. F3 · shares: As previously reported, on 2/10/2021, the reporting person was granted 36,832 RSUs, 1/3 of which vest annually over 3 years on the anniversary of the grant date. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. The number of derivative securities in column 5 includes 737 vested dividend equivalent rights. F3 · price: As previously reported, on 2/10/2021, the reporting person was granted 36,832 RSUs, 1/3 of which vest annually over 3 years on the anniversary of the grant date. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. The number of derivative securities in column 5 includes 737 vested dividend equivalent rights. F3 · derivative.exercise_date: As previously reported, on 2/10/2021, the reporting person was granted 36,832 RSUs, 1/3 of which vest annually over 3 years on the anniversary of the grant date. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. The number of derivative securities in column 5 includes 737 vested dividend equivalent rights. F3 · derivative.expiration_date: As previously reported, on 2/10/2021, the reporting person was granted 36,832 RSUs, 1/3 of which vest annually over 3 years on the anniversary of the grant date. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. The number of derivative securities in column 5 includes 737 vested dividend equivalent rights. Read SEC document |
| February 10, 2023 Filed Feb 14, 2023 22:01 UTC |
McQuarrie David P.Chief Commercial Officer
|
Tax withholdingCommon Stock | 4,678 | $29.97 | $140,199.66 |
DisclosureSEC source: 0001209191-23-009214 · doc4.xml · nonDerivative · entry 2 McQuarrie David P. · CIK 0001951912 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,887 F1 · shares: Shares withheld by HP to satisfy tax withholding upon vesting. Read SEC document |
| February 10, 2023 Filed Feb 14, 2023 22:01 UTC |
McQuarrie David P.Chief Commercial Officer
|
Exercise / conversionCommon Stock | 13,014 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-009214 · doc4.xml · nonDerivative · entry 1 McQuarrie David P. · CIK 0001951912 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,565 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 01, 2023 Filed Feb 2, 2023 22:47 UTC |
MYERS MARIEChief Financial Officer
|
SaleCommon Stock | 7,380 | $29.04 | $214,315.20 |
DisclosureSEC source: 0001209191-23-006314 · doc4.xml · nonDerivative · entry 1 MYERS MARIE · CIK 0001656326 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,936 F1 · kind: The sales reported on this Form 4 were executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 09/19/2022. Read SEC document |
| January 03, 2023 Filed Jan 4, 2023 22:05 UTC |
MYERS MARIEChief Financial Officer
|
SaleCommon Stock | 7,380 | $27.00 | $199,260.00 |
DisclosureSEC source: 0001209191-23-001080 · doc4.xml · nonDerivative · entry 1 MYERS MARIE · CIK 0001656326 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,316 F1 · kind: The sales reported on this Form 4 were executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 9/19/2022. Read SEC document |
| January 03, 2023 Filed Jan 4, 2023 22:03 UTC |
LORES ENRIQUEDirector · President and CEO
|
SaleCommon Stock | 34,000 | $27.13 | $922,420.00 |
DisclosureSEC source: 0001209191-23-001070 · doc4.xml · nonDerivative · entry 1 LORES ENRIQUE · CIK 0001656242 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 804,268 F1 · kind: The sales reported on this Form 4 were executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 6/7/2021. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.00-$27.25, inclusive. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| December 28, 2022 Filed Dec 29, 2022 22:11 UTC |
McQuarrie David P.Chief Commercial Officer
|
SaleCommon Stock | 20,609 | $26.64 | $549,023.76 |
DisclosureSEC source: 0001209191-22-062925 · doc4.xml · nonDerivative · entry 1 McQuarrie David P. · CIK 0001951912 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,551 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.630-$26.655, inclusive. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| December 13, 2022 Filed Dec 14, 2022 22:15 UTC |
Banerji ShumeetDirector
|
SaleCommon Stock | 17,300 | $29.53 | $510,869.00 |
DisclosureSEC source: 0001209191-22-061272 · doc4.xml · nonDerivative · entry 1 Banerji Shumeet · CIK 0001511649 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,708 Read SEC document |
| December 09, 2022 Filed Dec 13, 2022 01:20 UTC |
Tran TuanPres Imaging Prtng & Solutions
|
SaleCommon Stock | 54,115 | $28.33 | $1,533,077.95 |
DisclosureSEC source: 0001209191-22-060813 · doc4.xml · nonDerivative · entry 1 Tran Tuan · CIK 0001793233 · Pres Imaging Prtng & Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,465 F1 · kind: The sales reported on this Form 4 were executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 9/29/2022. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.23-$28.41, inclusive. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer the full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| December 09, 2022 Filed Dec 13, 2022 01:16 UTC |
Faust Jonathan PGlobal Controller
|
SaleCommon Stock | 6,028 | $28.37 | $171,014.36 |
DisclosureSEC source: 0001209191-22-060806 · doc4.xml · nonDerivative · entry 1 Faust Jonathan P · CIK 0001921172 · Global Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,647 F1 · kind: The sales reported on this Form 4 were executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 9/29/2022. Read SEC document |
| December 08, 2022 Filed Dec 13, 2022 01:20 UTC |
Tran TuanPres Imaging Prtng & Solutions
|
GrantPerformance Contingent Stock Options · Derivative | 192,418 | Not disclosed Strike: $28.48 | Not disclosed |
DisclosureSEC source: 0001209191-22-060813 · doc4.xml · derivative · entry 5 Tran Tuan · CIK 0001793233 · Pres Imaging Prtng & Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 192,418 Underlying: Common Stock · 192,418 shares Expires 2032-12-08 F8 · shares: On 12/8/2022, the reporting person was granted 192,418 performance contingent stock options, 1/3 of which vest annually over 3 years on the anniversary of the grant date, in each case subject to the satisfaction of certain stock price performance conditions. F8 · price: On 12/8/2022, the reporting person was granted 192,418 performance contingent stock options, 1/3 of which vest annually over 3 years on the anniversary of the grant date, in each case subject to the satisfaction of certain stock price performance conditions. F8 · derivative.exercise_date: On 12/8/2022, the reporting person was granted 192,418 performance contingent stock options, 1/3 of which vest annually over 3 years on the anniversary of the grant date, in each case subject to the satisfaction of certain stock price performance conditions. Read SEC document |
| December 08, 2022 Filed Dec 13, 2022 01:20 UTC |
Tran TuanPres Imaging Prtng & Solutions
|
GrantPerformance Adjusted Restricted Stock Units · Derivative | 54,362 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-060813 · doc4.xml · derivative · entry 4 Tran Tuan · CIK 0001793233 · Pres Imaging Prtng & Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,362 Underlying: Common Stock · 54,362 shares Expires not disclosed F6 · derivative.exercise_price: Each performance adjusted restricted stock unit ("PARSU") represents a contingent right to receive one share of HP common stock. F7 · shares: On 12/8/2022, the reporting person was granted 54,362 PARSUs, which will only be earned after certification of financial results as of October 31, 2025, subject to certain earnings per share and relative total stockholder return conditions being met as of that date. Depending on the level of achievement of such goals, the actual number of PARSUs earned can range from 0% to 300% of the target number of PARSUs shown in column 5. Dividend equivalent rights accrue with respect to these PARSUs when and as dividends are paid on HP common stock. F7 · price: On 12/8/2022, the reporting person was granted 54,362 PARSUs, which will only be earned after certification of financial results as of October 31, 2025, subject to certain earnings per share and relative total stockholder return conditions being met as of that date. Depending on the level of achievement of such goals, the actual number of PARSUs earned can range from 0% to 300% of the target number of PARSUs shown in column 5. Dividend equivalent rights accrue with respect to these PARSUs when and as dividends are paid on HP common stock. F7 · derivative.exercise_date: On 12/8/2022, the reporting person was granted 54,362 PARSUs, which will only be earned after certification of financial results as of October 31, 2025, subject to certain earnings per share and relative total stockholder return conditions being met as of that date. Depending on the level of achievement of such goals, the actual number of PARSUs earned can range from 0% to 300% of the target number of PARSUs shown in column 5. Dividend equivalent rights accrue with respect to these PARSUs when and as dividends are paid on HP common stock. F7 · derivative.expiration_date: On 12/8/2022, the reporting person was granted 54,362 PARSUs, which will only be earned after certification of financial results as of October 31, 2025, subject to certain earnings per share and relative total stockholder return conditions being met as of that date. Depending on the level of achievement of such goals, the actual number of PARSUs earned can range from 0% to 300% of the target number of PARSUs shown in column 5. Dividend equivalent rights accrue with respect to these PARSUs when and as dividends are paid on HP common stock. Read SEC document |
| December 08, 2022 Filed Dec 13, 2022 01:20 UTC |
Tran TuanPres Imaging Prtng & Solutions
|
GrantRestricted Stock Units · Derivative | 84,972 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-060813 · doc4.xml · derivative · entry 3 Tran Tuan · CIK 0001793233 · Pres Imaging Prtng & Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,972 Underlying: Common Stock · 84,972 shares Expires not disclosed F4 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of HP common stock. F5 · shares: On 12/8/2022, the reporting person was granted 84,972 RSUs, 1/3 of which vest annually over 3 years on the anniversary of 12/7/2022. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. F5 · price: On 12/8/2022, the reporting person was granted 84,972 RSUs, 1/3 of which vest annually over 3 years on the anniversary of 12/7/2022. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. F5 · derivative.exercise_date: On 12/8/2022, the reporting person was granted 84,972 RSUs, 1/3 of which vest annually over 3 years on the anniversary of 12/7/2022. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. F5 · derivative.expiration_date: On 12/8/2022, the reporting person was granted 84,972 RSUs, 1/3 of which vest annually over 3 years on the anniversary of 12/7/2022. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. Read SEC document |
| December 08, 2022 Filed Dec 13, 2022 01:19 UTC |
MYERS MARIEChief Financial Officer
|
GrantPerformance Contingent Stock Options · Derivative | 190,828 | Not disclosed Strike: $28.48 | Not disclosed |
DisclosureSEC source: 0001209191-22-060812 · doc4.xml · derivative · entry 3 MYERS MARIE · CIK 0001656326 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 190,828 Underlying: Common Stock · 190,828 shares Expires 2032-12-08 F5 · shares: On 12/8/2022, the reporting person was granted 190,828 performance contingent stock options, 1/3 of which vest annually over 3 years on the anniversary of the grant date, in each case subject to the satisfaction of certain stock price performance conditions. F5 · price: On 12/8/2022, the reporting person was granted 190,828 performance contingent stock options, 1/3 of which vest annually over 3 years on the anniversary of the grant date, in each case subject to the satisfaction of certain stock price performance conditions. F5 · derivative.exercise_date: On 12/8/2022, the reporting person was granted 190,828 performance contingent stock options, 1/3 of which vest annually over 3 years on the anniversary of the grant date, in each case subject to the satisfaction of certain stock price performance conditions. Read SEC document |
| December 08, 2022 Filed Dec 13, 2022 01:19 UTC |
MYERS MARIEChief Financial Officer
|
GrantPerformance Adjusted Restricted Stock Units · Derivative | 53,913 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-060812 · doc4.xml · derivative · entry 2 MYERS MARIE · CIK 0001656326 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,913 Underlying: Common Stock · 53,913 shares Expires not disclosed F3 · derivative.exercise_price: Each performance adjusted restricted stock unit ("PARSU") represents a contingent right to receive one share of HP common stock. F4 · shares: On 12/8/2022, the reporting person was granted 53,913 PARSUs, which will only be earned after certification of financial results as of October 31, 2025, subject to certain earnings per share and relative total stockholder return conditions being met as of that date. Depending on the level of achievement of such goals, the actual number of PARSUs earned can range from 0% to 300% of the target number of PARSUs shown in column 5. Dividend equivalent rights accrue with respect to these PARSUs when and as dividends are paid on HP common stock. F4 · price: On 12/8/2022, the reporting person was granted 53,913 PARSUs, which will only be earned after certification of financial results as of October 31, 2025, subject to certain earnings per share and relative total stockholder return conditions being met as of that date. Depending on the level of achievement of such goals, the actual number of PARSUs earned can range from 0% to 300% of the target number of PARSUs shown in column 5. Dividend equivalent rights accrue with respect to these PARSUs when and as dividends are paid on HP common stock. F4 · derivative.exercise_date: On 12/8/2022, the reporting person was granted 53,913 PARSUs, which will only be earned after certification of financial results as of October 31, 2025, subject to certain earnings per share and relative total stockholder return conditions being met as of that date. Depending on the level of achievement of such goals, the actual number of PARSUs earned can range from 0% to 300% of the target number of PARSUs shown in column 5. Dividend equivalent rights accrue with respect to these PARSUs when and as dividends are paid on HP common stock. F4 · derivative.expiration_date: On 12/8/2022, the reporting person was granted 53,913 PARSUs, which will only be earned after certification of financial results as of October 31, 2025, subject to certain earnings per share and relative total stockholder return conditions being met as of that date. Depending on the level of achievement of such goals, the actual number of PARSUs earned can range from 0% to 300% of the target number of PARSUs shown in column 5. Dividend equivalent rights accrue with respect to these PARSUs when and as dividends are paid on HP common stock. Read SEC document |
| December 08, 2022 Filed Dec 13, 2022 01:19 UTC |
MYERS MARIEChief Financial Officer
|
GrantRestricted Stock Units · Derivative | 84,270 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-060812 · doc4.xml · derivative · entry 1 MYERS MARIE · CIK 0001656326 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,270 Underlying: Common Stock · 84,270 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of HP common stock. F2 · shares: On 12/8/2022, the reporting person was granted 84,270 RSUs, 1/3 of which vest annually over 3 years on the anniversary of 12/7/2022. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. F2 · price: On 12/8/2022, the reporting person was granted 84,270 RSUs, 1/3 of which vest annually over 3 years on the anniversary of 12/7/2022. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. F2 · derivative.exercise_date: On 12/8/2022, the reporting person was granted 84,270 RSUs, 1/3 of which vest annually over 3 years on the anniversary of 12/7/2022. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. F2 · derivative.expiration_date: On 12/8/2022, the reporting person was granted 84,270 RSUs, 1/3 of which vest annually over 3 years on the anniversary of 12/7/2022. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. Read SEC document |
| December 08, 2022 Filed Dec 13, 2022 01:18 UTC |
McQuarrie David P.Chief Commercial Officer
|
GrantPerformance Contingent Stock Options · Derivative | 117,677 | Not disclosed Strike: $28.48 | Not disclosed |
DisclosureSEC source: 0001209191-22-060811 · doc4.xml · derivative · entry 3 McQuarrie David P. · CIK 0001951912 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,677 Underlying: Common Stock · 117,677 shares Expires 2032-12-08 F5 · shares: On 12/8/2022, the reporting person was granted 117,677 performance contingent stock options, 1/3 of which vest annually over 3 years on the anniversary of the grant date, in each case subject to the satisfaction of certain stock price performance conditions. F5 · price: On 12/8/2022, the reporting person was granted 117,677 performance contingent stock options, 1/3 of which vest annually over 3 years on the anniversary of the grant date, in each case subject to the satisfaction of certain stock price performance conditions. F5 · derivative.exercise_date: On 12/8/2022, the reporting person was granted 117,677 performance contingent stock options, 1/3 of which vest annually over 3 years on the anniversary of the grant date, in each case subject to the satisfaction of certain stock price performance conditions. Read SEC document |
| December 08, 2022 Filed Dec 13, 2022 01:18 UTC |
McQuarrie David P.Chief Commercial Officer
|
GrantPerformance Adjusted Restricted Stock Units · Derivative | 33,246 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-060811 · doc4.xml · derivative · entry 2 McQuarrie David P. · CIK 0001951912 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,246 Underlying: Common Stock · 33,246 shares Expires not disclosed F3 · derivative.exercise_price: Each performance adjusted restricted stock unit ("PARSU") represents a contingent right to receive one share of HP common stock. F4 · shares: On 12/8/2022, the reporting person was granted 33,246 PARSUs, which will only be earned after certification of financial results as of October 31, 2025, subject to certain earnings per share and relative total stockholder return conditions being met as of that date. Depending on the level of achievement of such goals, the actual number of PARSUs earned can range from 0% to 300% of the target number of PARSUs shown in column 5. Dividend equivalent rights accrue with respect to these PARSUs when and as dividends are paid on HP common stock. F4 · price: On 12/8/2022, the reporting person was granted 33,246 PARSUs, which will only be earned after certification of financial results as of October 31, 2025, subject to certain earnings per share and relative total stockholder return conditions being met as of that date. Depending on the level of achievement of such goals, the actual number of PARSUs earned can range from 0% to 300% of the target number of PARSUs shown in column 5. Dividend equivalent rights accrue with respect to these PARSUs when and as dividends are paid on HP common stock. F4 · derivative.exercise_date: On 12/8/2022, the reporting person was granted 33,246 PARSUs, which will only be earned after certification of financial results as of October 31, 2025, subject to certain earnings per share and relative total stockholder return conditions being met as of that date. Depending on the level of achievement of such goals, the actual number of PARSUs earned can range from 0% to 300% of the target number of PARSUs shown in column 5. Dividend equivalent rights accrue with respect to these PARSUs when and as dividends are paid on HP common stock. F4 · derivative.expiration_date: On 12/8/2022, the reporting person was granted 33,246 PARSUs, which will only be earned after certification of financial results as of October 31, 2025, subject to certain earnings per share and relative total stockholder return conditions being met as of that date. Depending on the level of achievement of such goals, the actual number of PARSUs earned can range from 0% to 300% of the target number of PARSUs shown in column 5. Dividend equivalent rights accrue with respect to these PARSUs when and as dividends are paid on HP common stock. Read SEC document |
| December 08, 2022 Filed Dec 13, 2022 01:18 UTC |
McQuarrie David P.Chief Commercial Officer
|
GrantRestricted Stock Units · Derivative | 51,966 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-060811 · doc4.xml · derivative · entry 1 McQuarrie David P. · CIK 0001951912 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,966 Underlying: Common Stock · 51,966 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of HP common stock. F2 · shares: On 12/8/2022, the reporting person was granted 51,966 RSUs, 1/3 of which vest annually over 3 years on the anniversary of 12/7/2022. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. F2 · price: On 12/8/2022, the reporting person was granted 51,966 RSUs, 1/3 of which vest annually over 3 years on the anniversary of 12/7/2022. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. F2 · derivative.exercise_date: On 12/8/2022, the reporting person was granted 51,966 RSUs, 1/3 of which vest annually over 3 years on the anniversary of 12/7/2022. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. F2 · derivative.expiration_date: On 12/8/2022, the reporting person was granted 51,966 RSUs, 1/3 of which vest annually over 3 years on the anniversary of 12/7/2022. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. Read SEC document |
| December 08, 2022 Filed Dec 13, 2022 01:18 UTC |
Ludgate Kristen MChief People Officer
|
GrantPerformance Contingent Stock Options · Derivative | 106,864 | Not disclosed Strike: $28.48 | Not disclosed |
DisclosureSEC source: 0001209191-22-060810 · doc4.xml · derivative · entry 3 Ludgate Kristen M · CIK 0001727434 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,864 Underlying: Common Stock · 106,864 shares Expires 2032-12-08 F5 · shares: On 12/8/2022, the reporting person was granted 106,864 performance contingent stock options, 1/3 of which vest annually over 3 years on the anniversary of the grant date, in each case subject to the satisfaction of certain stock price performance conditions. F5 · price: On 12/8/2022, the reporting person was granted 106,864 performance contingent stock options, 1/3 of which vest annually over 3 years on the anniversary of the grant date, in each case subject to the satisfaction of certain stock price performance conditions. F5 · derivative.exercise_date: On 12/8/2022, the reporting person was granted 106,864 performance contingent stock options, 1/3 of which vest annually over 3 years on the anniversary of the grant date, in each case subject to the satisfaction of certain stock price performance conditions. Read SEC document |
| December 08, 2022 Filed Dec 13, 2022 01:18 UTC |
Ludgate Kristen MChief People Officer
|
GrantPerformance Adjusted Restricted Stock Units · Derivative | 30,191 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-060810 · doc4.xml · derivative · entry 2 Ludgate Kristen M · CIK 0001727434 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,191 Underlying: Common Stock · 30,191 shares Expires not disclosed F3 · derivative.exercise_price: Each performance adjusted restricted stock unit ("PARSU") represents a contingent right to receive one share of HP common stock. F4 · shares: On 12/8/2022, the reporting person was granted 30,191 PARSUs, which will only be earned after certification of financial results as of October 31, 2025, subject to certain earnings per share and relative total stockholder return conditions being met as of that date. Depending on the level of achievement of such goals, the actual number of PARSUs earned can range from 0% to 300% of the target number of PARSUs shown in column 5. Dividend equivalent rights accrue with respect to these PARSUs when and as dividends are paid on HP common stock. F4 · price: On 12/8/2022, the reporting person was granted 30,191 PARSUs, which will only be earned after certification of financial results as of October 31, 2025, subject to certain earnings per share and relative total stockholder return conditions being met as of that date. Depending on the level of achievement of such goals, the actual number of PARSUs earned can range from 0% to 300% of the target number of PARSUs shown in column 5. Dividend equivalent rights accrue with respect to these PARSUs when and as dividends are paid on HP common stock. F4 · derivative.exercise_date: On 12/8/2022, the reporting person was granted 30,191 PARSUs, which will only be earned after certification of financial results as of October 31, 2025, subject to certain earnings per share and relative total stockholder return conditions being met as of that date. Depending on the level of achievement of such goals, the actual number of PARSUs earned can range from 0% to 300% of the target number of PARSUs shown in column 5. Dividend equivalent rights accrue with respect to these PARSUs when and as dividends are paid on HP common stock. F4 · derivative.expiration_date: On 12/8/2022, the reporting person was granted 30,191 PARSUs, which will only be earned after certification of financial results as of October 31, 2025, subject to certain earnings per share and relative total stockholder return conditions being met as of that date. Depending on the level of achievement of such goals, the actual number of PARSUs earned can range from 0% to 300% of the target number of PARSUs shown in column 5. Dividend equivalent rights accrue with respect to these PARSUs when and as dividends are paid on HP common stock. Read SEC document |
| December 08, 2022 Filed Dec 13, 2022 01:18 UTC |
Ludgate Kristen MChief People Officer
|
GrantRestricted Stock Units · Derivative | 47,191 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-060810 · doc4.xml · derivative · entry 1 Ludgate Kristen M · CIK 0001727434 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,191 Underlying: Common Stock · 47,191 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of HP common stock. F2 · shares: On 12/8/2022, the reporting person was granted 47,191 RSUs, 1/3 of which vest annually over 3 years on the anniversary of 12/7/2022. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. F2 · price: On 12/8/2022, the reporting person was granted 47,191 RSUs, 1/3 of which vest annually over 3 years on the anniversary of 12/7/2022. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. F2 · derivative.exercise_date: On 12/8/2022, the reporting person was granted 47,191 RSUs, 1/3 of which vest annually over 3 years on the anniversary of 12/7/2022. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. F2 · derivative.expiration_date: On 12/8/2022, the reporting person was granted 47,191 RSUs, 1/3 of which vest annually over 3 years on the anniversary of 12/7/2022. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.